| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.983 | 120 | 0 | 1986 | 2020 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.983 | 117 | 0 | 1986 | 2020 | |||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.100 | None | 0.987 | 76 | 0 | 1988 | 2020 | ||||||||
|
tripartite motif containing 21 | 0.485 | 0.808 | 3.4E-09 |
|
disease | 0.100 | None | 0.964 | 55 | 0 | 1982 | 2019 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.300 | None | 0.980 | 49 | 0 | 1996 | 2020 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.100 | None | 0.973 | 37 | 0 | 1992 | 2018 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 0.972 | 36 | 0 | 1995 | 2019 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.933 | 30 | 0 | 2005 | 2020 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 1.000 | 30 | 0 | 1988 | 2019 | |||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.857 | 28 | 0 | 2004 | 2018 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.100 | None | 0.893 | 28 | 0 | 2001 | 2020 | ||||||||
|
Ro60, Y RNA binding protein | 0.610 | 0.692 | 0.58 |
|
disease | 0.300 | None | 0.929 | 28 | 0 | 1987 | 2019 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2001 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 1.000 | 25 | 0 | 1991 | 2020 | ||||||||
|
small RNA binding exonuclease protection factor La | 0.612 | 0.692 | 9.0E-02 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 1984 | 2019 | ||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
disease | 0.700 | None | 0.957 | 23 | 0 | 1987 | 2018 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1994 | 2018 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2008 | 2019 | ||||||||
|
RNA binding region (RNP1, RRM) containing 3 | 0.608 | 0.731 | 2.0E-04 |
|
disease | 0.100 | None | 0.952 | 21 | 0 | 1984 | 2019 | ||||||||
|
CD70 molecule | 0.542 | 0.692 | 1.0E-02 |
|
disease | 0.100 | None | 0.952 | 21 | 0 | 2004 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 2008 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 1991 | 2019 | ||||||||
|
BTG anti-proliferation factor 3 | 0.528 | 0.808 | 0.92 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1977 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.889 | 18 | 0 | 2003 | 2020 | ||||||||
|
complement C4B (Chido blood group) | 0.603 | 0.808 | 0.83 |
|
disease | 0.600 | None | 0.944 | 18 | 0 | 1985 | 2019 |